Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) (International Journal of Clinical Oncology, (2018), 23, 5, (965-973), 10.1007/s10147-018-1281-8)

For the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

研究成果: Comment/debate査読

抄録

In the October 2018 issue of International Journal of Clinical Oncology, in the article titled “Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)” (volume 23, pages 965–973; doi: https ://doi.org/10.1007/s1014 7-018-1281-8.), by Hishiki T et al., there was a printing error in Figure 1. In the description for the schedule of the induction regime 05A1 and 05A3, the arrow that shows the day of pirarubicin administration was intended to indicate day 3, but in error had been published with the arrows indicating purarubicin administration on day 2. We sincerely apologize for this error in the schedule of the regime.

本文言語English
ページ(範囲)1744-1745
ページ数2
ジャーナルInternational Journal of Clinical Oncology
25
9
DOI
出版ステータスPublished - 2020 9 1

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

フィンガープリント 「Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) (International Journal of Clinical Oncology, (2018), 23, 5, (965-973), 10.1007/s10147-018-1281-8)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル